SCHEMBL9253696

SCHEMBL9253696

CCNC(=O)c1cnc2c(-c3cc(-c4ccccc4)cs3)cnn2c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
STAT1 P42224 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CSNK1D P48730 2/20 0.40
MARK3 P27448 1/20 0.40
HCAR2 Q8TDS4 3/20 0.39
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9168516 0.86 LMNA (0.45) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9165509 0.86 MAPT (0.44) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9165628 0.86 SMN1; SMN2 (0.47) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9165159 0.86 RAB9A (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9168212 0.85 NPC1 (0.60) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9166610 0.84 MAP2K1 (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9249831 0.84 RAB9A (0.40) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9166588 0.83 RAB9A (0.40) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9170564 0.83 NPC1 (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9172581 0.81 DYRK1A (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5420128-A Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-05-30 US disclosed
EP-0503099-A1 PYRIMIDINE DERIVATIVE, PRODUCTION THEREOF, AND ANDROGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-09-16 EP disclosed